Target intelligence / Profile preview

Suprachiasmatic nucleus (SCN)

Target
SCN
Molecular classification
Other
01

Overview

The suprachiasmatic nucleus (SCN) is a small group of neurons located in the hypothalamus above the optic chiasm and serves as the master circadian pacemaker in mammals[1][2][7]. It regulates daily physiological and behavioral rhythms, including the sleep-wake cycle, hormone secretion (notably influencing the pineal gland to produce melatonin at night), body temperature, feeding, and various neurohormonal outputs[1][2][7]. The SCN receives light input from the retina via the retinohypothalamic tract, using neurotransmitters such as glutamate and PACAP, and uses both cell-autonomous transcriptional feedback loops and network signaling to generate and synchronize circadian rhythms throughout the body[1][2][3]. Disruption of the SCN leads to sleep and mood disorders[1]. While signaling molecules and receptors within the SCN (e.g., vasopressin, VIP, GABA, PAC1-R) may be drug targets, the SCN itself is not considered a direct molecular therapeutic target—it is a brain structure rather than a protein, enzyme, or receptor[1][2][3][5]. Thus, "Suprachiasmatic nucleus signaling" refers to a brain signaling pathway or brain region, not a canonical drug target.

Other names
Suprachiasmatic nuclei
02

Mechanism of action

Melatonin—acts via melatonin receptors to modulate signals from the SCN to regulate sleep-wake cycles

03

Biological functions

Regulation of circadian rhythmsHomeostatic regulationHormone secretionCoordination of sleep-wake cycles
04

Disease associations

Sleep disordersMood disordersDisruption of circadian rhythmOther
05

Interacting drugs

Melatonin

Beyond the preview

Go deeper on Suprachiasmatic nucleus (SCN).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Suprachiasmatic nucleus (SCN).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call